<p><strong>BriaCell Therapeutics Corp</strong>（紐約證券交易所代碼：BCTX）的空頭頭寸佔流通股的比例自上次報告以來上升了 174.82%。根據交易所報告的數據，目前有 <strong>281,000 股被賣空</strong>，這佔所有可交易的普通股的 14.95%。根據其交易量，<strong>交易者平均需要 3.79 天來平倉他們的空頭頭寸。</strong></p>
<h3>為什麼空頭頭寸重要</h3>
<p>空頭頭寸是指已經被賣空但尚未平倉或關閉的股票數量。賣空 是指交易者出售他們並不擁有的公司的股票，希望價格下跌。如果股票價格下跌，交易者就能從賣空中獲利；如果價格上漲，他們則會虧損。</p>
<p>跟蹤空頭頭寸很重要，因為它可以作為市場對特定股票情緒的指標。空頭頭寸的增加可能表明投資者變得更加看跌，而空頭頭寸的減少則可能表明他們變得更加看漲。</p>
<p><strong>另見：</strong> 被賣空最多的股票列表</p>
<h3>BriaCell Therapeutics Corp 空頭頭寸圖表（3 個月）</h3>
<p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1768838442_0.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="short_fig" original-src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1768838442_0.png"/></p>
<p>從上面的圖表可以看出，BriaCell Therapeutics Corp 被賣空的股票比例自上次報告以來有所增長。這並不意味着該股票在短期內會下跌，但交易者應該意識到更多的股票正在被賣空。</p>
<h3>將 BriaCell Therapeutics Corp 的空頭頭寸與同行進行比較</h3>
<p>同行比較是分析師和投資者用來評估公司表現的一種流行技術。公司的同行是指在行業、規模、年齡和財務結構等方面具有相似特徵的其他公司。您可以通過閲讀公司的 10-K 報告、代理文件或進行自己的相似性分析來找到公司的同行羣體。</p>
<p>根據 Benzinga Pro，BriaCell Therapeutics Corp 的同行平均空頭頭寸佔流通股的比例為 2.71%，這意味着該公司的空頭頭寸 <strong>高於</strong> 大多數同行。</p>
<p><em>本文由 Benzinga 的自動內容引擎生成，並由編輯審核。</em></p>

BCTXZ

BCTXW

BCTX

標普生物技術 3 倍做空 - Direxion

<p>BriaCell Therapeutics Corp（紐約證券交易所代碼：BCTX）的空頭頭寸顯著上升，增加了 174.82%，達到 281,000 股，佔其流通股的 14.95%。這表明投資者的看跌情緒，因為做空意味着對價格下跌的預期。覆蓋空頭頭寸的平均時間為 3.79 天。與同行相比，BriaCell 的空頭頭寸明顯更高，類似公司的平均水平為 2.71%。這一趨勢可能表明交易者對該股票表現的日益謹慎</p>

<p><strong>BriaCell Therapeutics Corp's</strong> (NYSE: BCTX) short interest as a percent of float has risen 174.82% since its last report. According to exchange reported data, there are now <strong>281 thousand shares sold short</strong>, which is 14.95% of all regular shares that are available for trading. Based on its trading volume, <strong>it would take traders 3.79 days to cover their short positions on average.</strong></p>
<div class="lb-trans"><p><strong>BriaCell Therapeutics Corp</strong>（紐約證券交易所代碼：BCTX）的空頭頭寸佔流通股的比例自上次報告以來上升了 174.82%。根據交易所報告的數據，目前有 <strong>281,000 股被賣空</strong>，這佔所有可交易的普通股的 14.95%。根據其交易量，<strong>交易者平均需要 3.79 天來平倉他們的空頭頭寸。</strong></p>
</div><h3>Why Short Interest Matters</h3>
<div class="lb-trans"><h3>為什麼空頭頭寸重要</h3>
</div><p>Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.</p>
<div class="lb-trans"><p>空頭頭寸是指已經被賣空但尚未平倉或關閉的股票數量。賣空 是指交易者出售他們並不擁有的公司的股票，希望價格下跌。如果股票價格下跌，交易者就能從賣空中獲利；如果價格上漲，他們則會虧損。</p>
</div><p>Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.</p>
<div class="lb-trans"><p>跟蹤空頭頭寸很重要，因為它可以作為市場對特定股票情緒的指標。空頭頭寸的增加可能表明投資者變得更加看跌，而空頭頭寸的減少則可能表明他們變得更加看漲。</p>
</div><p><strong>See Also:</strong> List of the most shorted stocks</p>
<div class="lb-trans"><p><strong>另見：</strong> 被賣空最多的股票列表</p>
</div><h3>BriaCell Therapeutics Corp Short Interest Graph (3 Months)</h3>
<div class="lb-trans"><h3>BriaCell Therapeutics Corp 空頭頭寸圖表（3 個月）</h3>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1768838442_0.png" alt="short_fig" original-src="https://www.benzinga.com/files/images/story/2026/1768838442_0.png"/></p>
<p>As you can see from the chart above the percentage of shares that are sold short for BriaCell Therapeutics Corp has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.</p>
<div class="lb-trans"><p>從上面的圖表可以看出，BriaCell Therapeutics Corp 被賣空的股票比例自上次報告以來有所增長。這並不意味着該股票在短期內會下跌，但交易者應該意識到更多的股票正在被賣空。</p>
</div><h3>Comparing BriaCell Therapeutics Corp's Short Interest Against Its Peers</h3>
<div class="lb-trans"><h3>將 BriaCell Therapeutics Corp 的空頭頭寸與同行進行比較</h3>
</div><p>Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.</p>
<div class="lb-trans"><p>同行比較是分析師和投資者用來評估公司表現的一種流行技術。公司的同行是指在行業、規模、年齡和財務結構等方面具有相似特徵的其他公司。您可以通過閲讀公司的 10-K 報告、代理文件或進行自己的相似性分析來找到公司的同行羣體。</p>
</div><p>According to Benzinga Pro, BriaCell Therapeutics Corp's peer group average for short interest as a percentage of float is 2.71%, which means the company has <strong>more</strong> short interest than most of its peers.</p>
<div class="lb-trans"><p>根據 Benzinga Pro，BriaCell Therapeutics Corp 的同行平均空頭頭寸佔流通股的比例為 2.71%，這意味着該公司的空頭頭寸 <strong>高於</strong> 大多數同行。</p>
</div><p><em>This article was generated by Benzinga's automated content engine and was reviewed by an editor.</em></p>
<div class="lb-trans"><p><em>本文由 Benzinga 的自動內容引擎生成，並由編輯審核。</em></p>
</div>

市場對 BriaCell Therapeutics Corp 的態度是看漲還是看跌？